Andrx Relinquishes Exclusivity Rights To 150mg Generic Zyban
Generic drug maker Andrx Corp. has relinquished its right to a 180-day period of marketing exclusivity for the 150mg strength of GlaxoSmithKline's smoking cessation drug Zyban, under a deal in which...To view the full article, register now.
Already a subscriber? Click here to view full article